We are live on ! Find out more
RVPHW

Reviva Pharmaceuticals Warrants
RVPHW

Delisted

RVPHW was delisted on the 12th of December, 2025.

Back to rankings

12 hedge funds and large institutions have $2.01M invested in Reviva Pharmaceuticals Warrants in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 14 → 12 (-2)

47% less capital invested

Capital invested by funds: $3.8M → $2.01M (-$1.79M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$226K
2
VF
Virtu Financial
New York
+$9.13K
3
UBS Group
UBS Group
Switzerland
+$7.34K

Top Sellers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$197K
2
GCIA
Gabelli & Co Investment Advisers
New York
-$75K
3
GF
Gabelli Funds
New York
-$61K
4
BFM
Boothbay Fund Management
New York
-$50.2K
5
WAM
Wolverine Asset Management
Illinois
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$701K -$50.2K -77,840 -39%
BCM
2
BlueCrest Capital Management
Jersey
$561K – – –
GCL
3
Glazer Capital LLC
New York
$317K – – –
SM
4
Sabby Management
Florida
$161K +$226K +350,000 New
AA
5
AQR Arbitrage
Connecticut
$115K – – –
HF
6
HRT Financial
New York
$55K -$7.12K -11,048 -8%
RCM
7
Rivernorth Capital Management
Florida
$38K -$15.5K -24,071 -23%
Walleye Trading
8
Walleye Trading
New York
$27K -$69 -107 -0.2%
CCM
9
Context Capital Management
California
$18K – – –
VF
10
Virtu Financial
New York
$7K +$9.13K +14,169 New
UBS Group
11
UBS Group
Switzerland
$6K +$7.34K +11,393 +1,071%
Walleye Capital
12
Walleye Capital
New York
$30 – – –
PAMP
13
Polar Asset Management Partners
Ontario, Canada
– -$197K -300,907 Closed
GCIA
14
Gabelli & Co Investment Advisers
New York
– -$75K -110,900 Closed
GF
15
Gabelli Funds
New York
– -$61K -89,921 Closed
WAM
16
Wolverine Asset Management
Illinois
– -$28K -42,308 Closed

RVPHW Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q1 2021, worth a combined $2.01M — down 47% from $3.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RVPHW and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $226K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $197K sold.

  • 12 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q1 2021, down from 14 in Q4 2020.
  • Funds reported $2.01M of Reviva Pharmaceuticals Warrants stock for Q1 2021, down 47% quarter-over-quarter.
  • 2 funds opened new Reviva Pharmaceuticals Warrants positions in Q1 2021 and 4 closed out, a net change of -2 holders.
  • The largest Reviva Pharmaceuticals Warrants buyer in Q1 2021 was Sabby Management, an estimated $226K added.
  • The largest Reviva Pharmaceuticals Warrants seller in Q1 2021 was Polar Asset Management Partners, an estimated $197K sold.

Based on aggregated 13F filings for Q1 2021.